2021 IPO

Roivant Sciences Stock

Biopharmaceutical company

Sign up today and learn more about Roivant Sciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Roivant Sciences Stock

Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. It is a unique biopharmaceutical company with world-class drug development experts working across multiple clinical and functional areas.


Funding History

November 2018$200M
August 2017$1.1B
July 2016$500M
May 2014$93.0M


Co-Founder & Chief Executive Officer

Vivek Ramaswamy

Chief Information Officer

Daniel Rothman

Chief Financial Officer

Matthew Gline

Chief Accounting Officer

Rakhi Kumar


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: